Evidence map›Paper›PMID 36148319›Full record

ArticlePreventive medicine reports2022

COVID-19 vaccination acceptability and experiences among people who inject drugs in San Diego County.

Chad J Valasek, Samantha A Streuli, Heather A Pines, Maria Luisa Mittal, Steffanie A Strathdee, Carlos F Vera, Alicia Harvey-Vera, Angela R Bazzi

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chad J ValasekHerbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, Mail Code 0725, La Jolla, CA 92093-0725, USA.
Samantha A StreuliHerbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, Mail Code 0725, La Jolla, CA 92093-0725, USA.
Heather A PinesHerbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, Mail Code 0725, La Jolla, CA 92093-0725, USA.
Maria Luisa MittalSchool of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0507, La Jolla, CA 92093-0507 USA.
Steffanie A StrathdeeSchool of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0507, La Jolla, CA 92093-0507 USA.
Carlos F VeraSchool of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0507, La Jolla, CA 92093-0507 USA.
Alicia Harvey-VeraSchool of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0507, La Jolla, CA 92093-0507 USA.
Angela R BazziHerbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, Mail Code 0725, La Jolla, CA 92093-0725, USA.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIAID NIH HHS T32 AI007384NIDA NIH HHS R01 DA049644NIDA NIH HHS T32 DA023356
6 · The paper itself

Abstract

Background: People who inject drugs (PWID) face increased risk of SARS-CoV-2 acquisition and severe disease, yet COVID-19 vaccine uptake has been suboptimal. To inform vaccination interventions tailored for the needs of this population, we explored COVID-19 vaccination acceptability and experiences among PWID in San Diego County, USA. Methods: From September-November 2021, we conducted qualitative interviews with PWID aged ≥18 years who were participating in a prospective study of infectious disease risks in San Diego. Thematic analysis of coded interview transcripts focused on identifying barriers and facilitators to COVID-19 vaccination. Results: Of 28 participants, 15 reported having had ≥1 dose of COVID-19 vaccine, primarily received through community health centers, pharmacies, jails, and homeless shelters. We identified three key barriers to COVID-19 vaccination: (1) low perceived risk of COVID-19 (or belief in natural immunity), (2) institutional distrust (e.g., of pharmaceutical companies and government agencies that "rushed" vaccine development, approval, and distribution), and (3) conflicting information from news, social media, and peers. We also identified three key facilitators of vaccination, including (1) heightened personal and interpersonal safety concerns, (2) health service outreach efforts to make vaccines more accessible, and (3) tailored information delivered by trusted sources (e.g., outreach or community health workers). Conclusions: Tailored intervention strategies to increase acceptability and uptake of COVID-19 vaccination among PWID should involve efforts to increase vaccine literacy and motivation while decreasing institutional distrust and structural barriers to access.

Indexed as

COVID-19People who inject drugsVaccinationsVaccine acceptabilityVaccine hesitancy

Identifiers

PMID36148319
PMCPMC9484100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.